Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) — The “Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses & Lens), End User – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering.
The global ophthalmology market is currently experiencing a significant surge, with a robust growth forecast from 2023 to 2030. Industry analysis reveals that the market size, valued at USD 56.20 billion in 2022, is expected to reach an impressive USD 93.99 billion by 2030. This growth is attributed to a compound annual growth rate (CAGR) of 6.63%, as reported in a new research publication added to our comprehensive online resource.
Advancements in ophthalmology, including treatments for age-related macular degeneration, cataracts, and glaucoma, alongside the proliferation of prescription glasses and lenses, are driving the market’s expansion. The rise in eye disorders combined with increased global awareness has created a demand for ophthalmologic care that shows no sign of abating.
With a detailed market segmentation analysis, the report covers diseases such as age-related macular degeneration, cataract, and glaucoma, as well as product types ranging from drugs, equipment, and prescription lenses. It also delves into the end-user perspective, including healthcare service providers, hospitals, and research organizations.
Regional Growth Dynamics
Regions such as the U.S., Canada, China, India, and Germany are critical growth areas, with access to ophthalmology care facilities and innovative treatment devices continually improving. The Asia-Pacific market is specifically witnessing a unique growth trajectory, fueled by regional manufacturers that cater to the demands of the local populace for eyeglasses and related ophthalmology products.
Strategic Market Analysis
The research includes an FPNV Positioning Matrix and Market Share Analysis, providing an in-depth examination of vendor contributions and competitive market dynamics. These analytical tools offer both existing and potential market participants valuable insights into strategic placement and the pursuit of market share.
Key Players Shaping the Market
Several renowned companies feature prominently within the ophthalmology sector. The report highlights their cutting-edge developments, expanding product portfolios, and strategic industry positioning. These market leaders are innovating in areas such as diagnostics, prescription glasses, drugs for various eye diseases, and advanced surgical equipment.
Comprehensive Coverage of Market Segmentation
Within the report, readers can find segmentation analyses covering diseases, product types, and end users, alongside granular insights into significant sub-markets. Geographical breakdowns provide regional and country-level data, underscoring growth trends and opportunities across the Americas, Asia-Pacific, and Europe, Middle East & Africa.
Forward-Looking Insights
The ophthalmology market report offers foresight into emerging trends, market development strategies, diversification opportunities, and competitive benchmarking that could shape the future of this vibrant industry.
The publication answers pivotal questions related to market size, investment opportunities, technological and regulatory trends, market share distribution, and strategic approaches pertinent to entering the Ophthalmology Market.
The findings present an indispensable resource for stakeholders and decision-makers in the healthcare industry, aiming to navigate the complexities of the ophthalmology market and capitalize on its growth prospects.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $59.9 Billion |
| Forecasted Market Value (USD) by 2030 | $93.99 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
Key Topics Covered:
- Market Dynamics:
- Rising prevalence of eye disorders and growing awareness among the population
- Increasing adoption of prescription glasses and lenses
- Presence of well-equipped healthcare infrastructure and increasing number of drugs approvals
- High cost of ophthalmologic treatments
- Market Trend Analysis:
- Emergence of telehealth and expansion of ophthalmology care across Americas
- Start-ups focusing on developing ophthalmology drugs with increasing need due to prevalence of blindness & vision impairment in Asia-Pacific
- Surging research activities and continuous technological advancements in ophthalmology therapeutics in EMEA
- Opportunities & Challenges:
- Emerging research activities of ophthalmology treatments and availability of grants
- High usage potential owing to the technological integrations in Ophthalmology
- Limited skilled professionals for ophthalmic procedures
- Market Segmentation Analysis:
- Analysis of various diseases such as Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders
- Regional Analysis:
- Americas Ophthalmology Market
- Asia-Pacific Ophthalmology Market
- Europe, Middle East & Africa Ophthalmology Market
- Competitive Landscape:
- FPNV Positioning Matrix
- Market Share Analysis, By Key Player
- Competitive Scenario Analysis, including M&A, Agreements, Partnerships, New Product Launches, and Investments/Funding
Companies Mentioned
- AbbVie Inc.
- Alcon Inc.
- Alkeus Pharmaceuticals, Inc.
- Apotex Inc.
- Bausch + Lomb Corporation
- C.H. Boehringer Sohn AG & Co. KG
- Carl Zeiss AG
- ClearSight
- CooperVision, Inc.
- Duopharma Consumer Healthcare Sdn Bhd
- Essex Bio-Technology Limited
- EssilorLuxottica S.A.
- Eyenovia, Inc.
- F. Hoffmann-La Roche AG
- GenSight Biologics S.A.
- Geri-Care Pharmaceuticals Corp.
- Glaukos Corporation
- Halma PLC
- Harrow Health, Inc.
- Honeywell International Inc.
- Hoya Corporation
- Johnson & Johnson Services Inc.
- Kubota Pharmaceutical Holdings Co., Ltd.
- Lumenis Be Ltd.
- Nidek Co., Ltd.
- Novartis AG
- OCuSOFT, Inc.
- Oxurion NV
- Pfizer, Inc.
- PharmOptima LLC
- Santen Pharmaceutical Co., Ltd.
- SEED Co., Ltd.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
- Topcon Corporation
- Unimed Pharma, Spols r.o.
- Visioncare Optolab Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/602jaq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Ophthalmology Market
